Answer
The selected injection product is licensed for conversion of paroxysmal supraventricular tachycardia in children. The selected infusion product is licensed for adults, with paediatric diagnostic evidence considered insufficient.
Sources for this answer
- Adenosine 3mg/ml Solution for Injection (Focus) — Current selected SmPCemc · Summary of Product Characteristics
- Adenosine 30mg/10ml Solution for Infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.